Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laith Q Al-Mawsawi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Chemmedchem|January 29, 2011
Allosteric inhibitor development targeting HIV-1 integraseLaith Q Al-Mawsawi, Nouri Neamati
Trends in Pharmacological Sciences|September 25, 2007
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategyLaith Q Al-Mawsawi, Nouri Neamati
Drug News & Perspectives|December 25, 2010
Are we living in the end of the blockbuster drug era?Bikash Debnath, Laith Q Al-Mawsawi, Nouri Neamati
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Substituted 2-pyrrolinone inhibitors of HIV-1 integraseRaveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati
Drugs in R&D|May 3, 2007
HIV-1 integrase inhibitors: an emerging clinical realityRaveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati
FEBS Letters|March 3, 2007
Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivityLaith Q Al-Mawsawi, Mario Sechi, Nouri Neamati
Current Pharmaceutical Design|February 3, 2007
Design of second generation HIV-1 integrase inhibitorsJinxia Deng, Raveendra Dayam, Laith Q Al-Mawsawi, et al.
Medicinal Research Reviews|November 6, 2007
HIV-1 integrase inhibitors: 2005-2006 updateRaveendra Dayam, Rambabu Gundla, Laith Q Al-Mawsawi, et al.
Expert Opinion on Emerging Drugs|June 10, 2008
Anti-infectives: clinical progress of HIV-1 integrase inhibitorsLaith Q Al-Mawsawi, Rasha I Al-Safi, Nouri Neamati
Virology|June 3, 2008
Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivityLaith Q Al-Mawsawi, Anneleen Hombrouck, Raveendra Dayam, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Chemmedchem|January 29, 2011
Allosteric inhibitor development targeting HIV-1 integraseLaith Q Al-Mawsawi, Nouri Neamati
Trends in Pharmacological Sciences|September 25, 2007
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategyLaith Q Al-Mawsawi, Nouri Neamati
Drug News & Perspectives|December 25, 2010
Are we living in the end of the blockbuster drug era?Bikash Debnath, Laith Q Al-Mawsawi, Nouri Neamati
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Substituted 2-pyrrolinone inhibitors of HIV-1 integraseRaveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati
Drugs in R&D|May 3, 2007
HIV-1 integrase inhibitors: an emerging clinical realityRaveendra Dayam, Laith Q Al-Mawsawi, Nouri Neamati
FEBS Letters|March 3, 2007
Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivityLaith Q Al-Mawsawi, Mario Sechi, Nouri Neamati
Current Pharmaceutical Design|February 3, 2007
Design of second generation HIV-1 integrase inhibitorsJinxia Deng, Raveendra Dayam, Laith Q Al-Mawsawi, et al.
Medicinal Research Reviews|November 6, 2007
HIV-1 integrase inhibitors: 2005-2006 updateRaveendra Dayam, Rambabu Gundla, Laith Q Al-Mawsawi, et al.
Expert Opinion on Emerging Drugs|June 10, 2008
Anti-infectives: clinical progress of HIV-1 integrase inhibitorsLaith Q Al-Mawsawi, Rasha I Al-Safi, Nouri Neamati
Virology|June 3, 2008
Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivityLaith Q Al-Mawsawi, Anneleen Hombrouck, Raveendra Dayam, et al.
Pageof 3